Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Pancreatic Disorders
Questions discussed in this category
How would you manage autoimmune pancreatitis in a patient after Whipple's procedure?
1 Answer available
What is your treatment algorithm for management of retroperitoneal fibrosis that does not respond to high-dose glucocorticoids?
1 Answer available
When would you consider rituximab as induction therapy in IgG4-related disease?
4 Answers available
Would you intensify therapy in IgG4 related disease based solely on a persistently significantly elevated IgG4 level when all disease manifestations and inflammatory markers have normalized?
1 Answer available
How do you approach a patient with IgG4-related disease who has failed rituximab and mycophenolate and continues to rely on high-dose steroids?
The case I am considering involves a patient with biopsy-proven fibrosing dacryoadenitis.
1 Answer available
17960
14098
12325
12203
9879
Papers discussed in this category
Annals of the rheumatic diseases, 2015-06
Rituximab for IgG4-related disease: a prospective, open-label trial.
Neth J Med,
The treatment outcomes in IgG4-related disease.
Medicine (Baltimore),
Therapeutic approach to IgG4-related disease: A systematic review.
Related Topics
Internal Medicine
Gastroenterology
Rheumatology
IgG4-Related Disease
General Gastroenterology
General Rheumatology
Retroperitoneal fibrosis
Nephrology